HI
GILD icon

Humankind Investments’s Gilead Sciences GILD Stock Holding History

Humankind Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,757
Closed -$1.42M – 81
2025
Q3 		$1.42M Sell
12,757
-1,393
-10% -$158K 0.32% 41
2025
Q2 		$1.57M Buy
14,150
+4,080
+41% +$434K 0.38% 37
2025
Q1 		$1.13M Sell
10,070
-2,187
-18% -$226K 0.29% 51
2024
Q4 		$1.13M Sell
12,257
-1,891
-13% -$170K 0.29% 50
2024
Q3 		$1.19M Sell
14,148
-489
-3% -$37.3K 0.43% 44
2024
Q2 		$1M Buy
14,637
+1,116
+8% +$74.5K 0.27% 52
2024
Q1 		$990K Buy
13,521
+1,683
+14% +$129K 0.26% 49
2023
Q4 		$959K Buy
11,838
+31
+0.3% +$2.41K 0.28% 50
2023
Q3 		$885K Buy
11,807
+344
+3% +$26.5K 0.37% 39
2023
Q2 		$883K Buy
11,463
+799
+7% +$63.7K 0.35% 41
2023
Q1 		$885K Sell
10,664
-126
-1% -$10.4K 0.37% 41
2022
Q4 		$926K Sell
10,790
-3,009
-22% -$238K 0.4% 37
2022
Q3 		$851K Buy
13,799
+1,971
+17% +$124K 0.41% 35
2022
Q2 		$731K Sell
11,828
-1,867
-14% -$116K 0.35% 42
2022
Q1 		$814K Buy
13,695
+1,928
+16% +$123K 0.33% 40
2021
Q4 		$854K Buy
11,767
+1,817
+18% +$125K 1.08% 28
2021
Q3 		$695K Buy
9,950
+1,364
+16% +$95.8K 1.06% 31
2021
Q2 		$591K Buy
8,586
+3,159
+58% +$211K 1.05% 31
2021
Q1 		$351K Buy
+5,427
New +$350K 1.08% 34

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Humankind Investments's GILD Position: Q4 2025 in Review

Humankind Investments sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 12,757 shares — an estimated $1.42M sold.

Humankind Investments first reported a position in GILD in Q1 2021 and held it in 19 quarters. The position peaked at $1.57M in Q2 2025. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Humankind Investments reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 12,757 Gilead Sciences shares in Q4 2025, an estimated $1.42M.
  • Humankind Investments first reported a position in Gilead Sciences in Q1 2021 and held it in 19 quarters.
  • Humankind Investments's Gilead Sciences position peaked at $1.57M in Q2 2025.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.